In today’s rapidly evolving business landscape, mergers and acquisitions (“M&A”) remain a common strategic priority for companies aiming to grow, innovate, or strengthen their market position. However ...

China’s top court has issued a new interpretation clarifying how patent lawsuits should be conducted. Shenping Yang and Zhongkui Li of Beijing Tongdaxinheng explain how it will affect litigation in ...

A Perfect Storm for Increased Patent Litigation in 2026 2026 is expected to be a record year for U.S. patent litigation, driven by pro-patent policies, advanced AI tools, and increased litigation ...

An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...

Each year, companies invest significant financial resources building and maintaining patent portfolios. But instead of ...

“The factors driving perception that patents have lost their value are certainly relevant and have had a substantial impact on patent litigation [but] none of these factors, alone or in combination, ...

Firms reflect on how they’re managing their design patent practices as brands seek to enforce their rights at the Northern District of Illinois and beyond Design patent litigation has spiked in recent ...

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.

Third party litigation funding is the process where third party funders provide money to a plaintiff or to plaintiff’s counsel in exchange for a cut of the proceeds resulting from the underlying ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...